3-aminoisobutyric acid has been researched along with Diabetes Mellitus, Type 2 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Fujisawa, Y; Fujito, T; Furuhashi, M; Katano, S; Katayose, M; Kouzu, H; Kuno, A; Nagano, N; Nagaoka, R; Nishikawa, R; Numazawa, R; Ohori, K; Ohwada, W; Sato, T; Yamano, K; Yano, T | 1 |
Bai, DD; Xiao, WH | 1 |
Andrianou, XD; Charisiadis, P; Makris, KC | 1 |
Bode-Böger, SM; Bornstein, SR; Brilloff, S; Brocker, C; Burdin, DV; Demyanov, AV; Gonzalez, F; Jarzebska, N; Kolobov, AA; Maas, R; Martens-Lobenhoffer, J; Mieth, M; Rodionov, RN; Samusik, N; Soshnev, AA; Weiss, N | 1 |
Preĭksha, RA; Spitsyn, VA; Stakishaĭtis, DV | 1 |
5 other study(ies) available for 3-aminoisobutyric acid and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors.
Topics: Aged; Aminoisobutyric Acids; Diabetes Mellitus, Type 2; Female; Glucose; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Sodium; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
[Regulatory effects and mechanisms of branched chain amino acids and metabolic intermediates on insulin resistance].
Topics: Amino Acids, Branched-Chain; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Resistance; Keto Acids | 2023 |
Coupling Urinary Trihalomethanes and Metabolomic Profiles of Type II Diabetes: A Case-Control Study.
Topics: Aged; Aminoisobutyric Acids; Case-Control Studies; Diabetes Mellitus, Type 2; Environmental Exposure; Female; Gas Chromatography-Mass Spectrometry; Greece; Humans; Male; Metabolomics; Middle Aged; Risk Factors; Trihalomethanes; Water Pollutants, Chemical | 2017 |
Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2.
Topics: Aminoisobutyric Acids; Animals; Arginine; Cardiovascular Diseases; Cell Line; Diabetes Mellitus, Type 2; Gene Expression Regulation; Hepatocyte Nuclear Factor 4; Humans; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk; RNA, Small Interfering; Transaminases | 2016 |
[Genetic dimorphism in beta-aminoisobutyric acid excretion in patients with atherosclerosis of the coronary artery and in groups at risk for atherosclerosis in the Lithuanian population].
Topics: Adolescent; Adult; Aminoisobutyric Acids; Child; Child, Preschool; Coronary Artery Disease; Cytomegalovirus Infections; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Lithuania; Middle Aged; Polymorphism, Genetic; Respiratory Tract Infections; Risk Factors; Virus Diseases | 1993 |